Regeneron and Icahn School of Medicine at Mount Sinai Announce New Antibody Research Agreement
September 24, 2015 at 08:38 AM EDT
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and The Experimental Therapeutics Institute (ETI) at the Icahn School of Medicine at ...
